The single biggest cost-driver for the health care system is new health technologies: new diagnostic and treatment tools including pharmaceuticals. Will these new technologies truly improve patient care? Are they cost-effective? How can we evaluate this? These are challenging questions for health care providers and managers.
Dr. Maurice McGregor is president of the Technology Assessment Unit of the MUHC. He is a pioneer and a champion of health technology assessment (HTA) as a systematic approach to evaluating new technologies and reaching evidence-based conclusions about their use. The following four talks provide an overview of this still novel approach.
|1: What is health technology assessment? (mp3)|
|2: How did HTA develop? (mp3)|
|3: Can HTA help health care systems contain rising health costs? (mp3)|
|4: The MUHC experience: Is HTA helpful in the hospital setting? (mp3)|